1-110593985-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_004974.4(KCNA2):c.*9298G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,547,722 control chromosomes in the GnomAD database, including 1,394 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.053 ( 750 hom., cov: 30)
Exomes 𝑓: 0.0055 ( 644 hom. )
Consequence
KCNA2
NM_004974.4 3_prime_UTR
NM_004974.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.52
Publications
0 publications found
Genes affected
KCNA2 (HGNC:6220): (potassium voltage-gated channel subfamily A member 2) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. Four sequence-related potassium channel genes - shaker, shaw, shab, and shal - have been identified in Drosophila, and each has been shown to have human homolog(s). This gene encodes a member of the potassium channel, voltage-gated, shaker-related subfamily. This member contains six membrane-spanning domains with a shaker-type repeat in the fourth segment. It belongs to the delayed rectifier class, members of which allow nerve cells to efficiently repolarize following an action potential. The coding region of this gene is intronless, and the gene is clustered with genes KCNA3 and KCNA10 on chromosome 1. [provided by RefSeq, Jul 2008]
KCNA2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 32Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 1-110593985-C-T is Benign according to our data. Variant chr1-110593985-C-T is described in ClinVar as [Benign]. Clinvar id is 1237563.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0530 AC: 8058AN: 152086Hom.: 746 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
8058
AN:
152086
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00546 AC: 7620AN: 1395518Hom.: 644 Cov.: 30 AF XY: 0.00473 AC XY: 3259AN XY: 688306 show subpopulations
GnomAD4 exome
AF:
AC:
7620
AN:
1395518
Hom.:
Cov.:
30
AF XY:
AC XY:
3259
AN XY:
688306
show subpopulations
African (AFR)
AF:
AC:
6053
AN:
31458
American (AMR)
AF:
AC:
337
AN:
35388
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
25078
East Asian (EAS)
AF:
AC:
0
AN:
35584
South Asian (SAS)
AF:
AC:
37
AN:
78704
European-Finnish (FIN)
AF:
AC:
0
AN:
47946
Middle Eastern (MID)
AF:
AC:
45
AN:
5688
European-Non Finnish (NFE)
AF:
AC:
389
AN:
1077772
Other (OTH)
AF:
AC:
758
AN:
57900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
313
626
939
1252
1565
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0531 AC: 8078AN: 152204Hom.: 750 Cov.: 30 AF XY: 0.0513 AC XY: 3818AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
8078
AN:
152204
Hom.:
Cov.:
30
AF XY:
AC XY:
3818
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
7650
AN:
41484
American (AMR)
AF:
AC:
290
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
5
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
43
AN:
68016
Other (OTH)
AF:
AC:
85
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
326
652
978
1304
1630
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
31
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.